ARCA Biopharma Inc (NASDAQ:ABIO)
| 1.63 Data as of 3:59pm ET |  -0.06 / -3.55%Today’s Change | 1.13 Today|||52-Week Range 2.80 | -2.98% Year-to-Date |
Latest ABIO News | Press Releases
Today’s Trading
| Previous close | 1.69 |
| Today’s open | 1.69 |
| Day’s range | 1.60 - 1.70 |
| Volume | 274,704 |
| Average volume (3 months) | 851,314 |
| Market cap | $38.4M |
| Dividend yield | -- |
Data as of 3:59pm ET, 04/24/2014
Growth & Valuation
| Earnings growth (last year) | +46.39% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTRVContraVir Pharmaceut... | +0.05 | +2.70% |
| ECTEEcho Therapeutics In... | 0.00 | 0.00% |
| SKBISkystar Bio-Pharmace... | +0.03 | +0.48% |
| ENZNEnzon Pharmaceutical... | -0.04 | -3.85% |
Data as of 3:59pm ET, 04/24/2014
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Financial Officer Patrick M. Wheeler |
Corporate headquarters Westminster, Colorado |
Forecasts
